DAVID P KING Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID P KING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID P KING. DAVID P KING is Director in CARDINAL HEALTH INC ($CAH) and Director in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, Strategic Planning in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, Strategic Planning & Dev in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and President & CEO in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and Director in Privia Health Group, Inc. ($PRVA).
Latest Insider Trading Transactions of DAVID P KING
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | PRVA | Privia Health Grou ... | KING DAVID P | Director | Grant | A | 0.00 | 7,609 | 0 | 7,609 | 0 to 7.6 K |
Apr 30 2021 | PRVA | Privia Health Grou ... | KING DAVID P | Director | Grant | A | 0.00 | 7,609 | 0 | 7,609 | 0 to 7.6 K |
May 07 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Sell | S | 160.00 | 31,250 | 5,000,000 | 312,554 | 343.8 K to 312.6 K (-9.09 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Payment of Exercise | F | 131.95 | 24,583 | 3,243,727 | 343,804 | 368.4 K to 343.8 K (-6.67 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Payment of Exercise | F | 131.95 | 24,583 | 3,243,727 | 343,804 | 368.4 K to 343.8 K (-6.67 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Grant | A | 0.00 | 54,995 | 0 | 368,387 | 313.4 K to 368.4 K (+17.55 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Grant | A | 0.00 | 54,995 | 0 | 368,387 | 313.4 K to 368.4 K (+17.55 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Option Exercise | M | 0.00 | 4,236 | 0 | 50,558 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Option Exercise | M | 0.00 | 3,513 | 0 | 54,794 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Payment of Exercise | F | 187.51 | 1,894 | 355,144 | 313,392 | 315.3 K to 313.4 K (-0.60 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Buy | M | 0.00 | 4,236 | 0 | 315,286 | 311.1 K to 315.3 K (+1.36 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Payment of Exercise | F | 187.51 | 1,386 | 259,889 | 311,050 | 312.4 K to 311.1 K (-0.44 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Buy | M | 0.00 | 3,513 | 0 | 312,436 | 308.9 K to 312.4 K (+1.14 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Option Exercise | M | 0.00 | 4,220 | 0 | 58,307 | |
Feb 11 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Payment of Exercise | F | 182.33 | 1,252 | 228,277 | 308,923 | 310.2 K to 308.9 K (-0.40 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Buy | M | 0.00 | 4,220 | 0 | 310,175 | 306 K to 310.2 K (+1.38 %) |
Jan 03 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Option Exercise | A | 0.00 | 38,570 | 0 | 62,527 | |
Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.21 | 12,352 | 2,053,053 | 305,933 | 318.3 K to 305.9 K (-3.88 %) |
Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.32 | 10,391 | 1,717,832 | 318,285 | 328.7 K to 318.3 K (-3.16 %) |
Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 164.16 | 7,434 | 1,220,332 | 328,676 | 336.1 K to 328.7 K (-2.21 %) |
Apr 03 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 154.79 | 41,311 | 6,394,530 | 297,387 | 338.7 K to 297.4 K (-12.20 %) |
Apr 03 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 92,417 | 0 | 338,698 | 246.3 K to 338.7 K (+37.53 %) |
Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 146.59 | 52,300 | 7,666,657 | 52,300 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 12,710 | 0 | 23,957 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 3,513 | 0 | 11,247 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 146.59 | 1,571 | 230,293 | 246,281 | 247.9 K to 246.3 K (-0.63 %) |
Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 3,513 | 0 | 247,852 | 244.3 K to 247.9 K (+1.44 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,544 | 0 | 14,760 | |
Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 144.29 | 2,980 | 429,984 | 244,339 | 247.3 K to 244.3 K (-1.20 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,544 | 0 | 247,319 | 239.8 K to 247.3 K (+3.15 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 22,304 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 147.46 | 1,254 | 184,915 | 239,775 | 241 K to 239.8 K (-0.52 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 241,029 | 236.8 K to 241 K (+1.78 %) |
Aug 15 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 695 | 0 | 219,711 | 220.4 K to 219.7 K (-0.32 %) |
Aug 15 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 1,389 | 0 | 220,406 | 221.8 K to 220.4 K (-0.63 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,966 | 4,240,115 | 0 | |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 176.13 | 5,400 | 951,092 | 221,669 | 227.1 K to 221.7 K (-2.38 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 175.27 | 44,566 | 7,811,252 | 227,069 | 271.6 K to 227.1 K (-16.41 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,966 | 4,240,115 | 271,635 | 221.7 K to 271.6 K (+22.54 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,967 | 4,240,200 | 49,966 | |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.37 | 21,200 | 3,526,985 | 221,669 | 242.9 K to 221.7 K (-8.73 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.94 | 28,767 | 4,773,711 | 242,869 | 271.6 K to 242.9 K (-10.59 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,967 | 4,240,200 | 271,636 | 221.7 K to 271.6 K (+22.54 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 161.75 | 33,015 | 5,340,176 | 221,669 | 254.7 K to 221.7 K (-12.96 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 73,449 | 0 | 254,684 | 181.2 K to 254.7 K (+40.53 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,967 | 4,240,200 | 99,933 | |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.38 | 1,700 | 282,838 | 181,235 | 182.9 K to 181.2 K (-0.93 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.39 | 10,313 | 1,705,658 | 182,935 | 193.2 K to 182.9 K (-5.34 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 164.55 | 36,265 | 5,967,435 | 193,248 | 229.5 K to 193.2 K (-15.80 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 163.58 | 1,689 | 276,287 | 229,513 | 231.2 K to 229.5 K (-0.73 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,967 | 4,240,200 | 231,202 | 181.2 K to 231.2 K (+27.57 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 6,077 | 0 | 26,524 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 175.61 | 2,732 | 479,767 | 181,235 | 184 K to 181.2 K (-1.49 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 6,077 | 0 | 183,967 | 177.9 K to 184 K (+3.42 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 168.49 | 41,000 | 6,908,090 | 41,000 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 10,540 | 0 | 32,601 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,543 | 0 | 22,061 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 168.08 | 3,138 | 527,435 | 177,890 | 181 K to 177.9 K (-1.73 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,543 | 0 | 181,028 | 173.5 K to 181 K (+4.35 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 29,604 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 169.66 | 1,264 | 214,450 | 173,485 | 174.7 K to 173.5 K (-0.72 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 174,749 | 170.5 K to 174.7 K (+2.47 %) |
Nov 09 2017 | CAH | CARDINAL HEALTH IN ... | KING DAVID P | Director | Grant | A | 0.00 | 2,623 | 0 | 21,044 | 18.4 K to 21 K (+14.24 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 90.74 | 44,687 | 4,054,898 | 0 | |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 157.34 | 7,500 | 1,180,022 | 214,066 | 221.6 K to 214.1 K (-3.38 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 156.77 | 37,187 | 5,829,761 | 221,566 | 258.8 K to 221.6 K (-14.37 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 90.74 | 44,687 | 4,054,898 | 258,753 | 214.1 K to 258.8 K (+20.88 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 90.74 | 132,713 | 12,042,378 | 44,687 | |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 157.06 | 132,713 | 20,843,373 | 214,066 | 346.8 K to 214.1 K (-38.27 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 90.74 | 132,713 | 12,042,378 | 346,779 | 214.1 K to 346.8 K (+62.00 %) |
Sep 07 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 1,650 | 0 | 214,066 | 215.7 K to 214.1 K (-0.76 %) |
Mar 31 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 143.19 | 48,596 | 6,958,461 | 198,359 | 247 K to 198.4 K (-19.68 %) |
Mar 31 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 102,200 | 0 | 246,955 | 144.8 K to 247 K (+70.60 %) |
Mar 14 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 6,077 | 0 | 33,824 | |
Mar 14 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 144.24 | 2,890 | 416,854 | 144,755 | 147.6 K to 144.8 K (-1.96 %) |
Mar 14 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 6,077 | 0 | 147,645 | 141.6 K to 147.6 K (+4.29 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,543 | 0 | 48,245 | |
Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 133.83 | 2,496 | 334,040 | 137,192 | 139.7 K to 137.2 K (-1.79 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,543 | 0 | 139,688 | 132.1 K to 139.7 K (+5.71 %) |
Feb 09 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 130.60 | 48,300 | 6,307,980 | 48,300 | |
Feb 09 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 12,660 | 0 | 55,788 | |
Nov 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 31,601 | 0 | 31,601 | 0 to 31.6 K |
Nov 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 31,601 | 0 | 132,104 | 163.7 K to 132.1 K (-19.30 %) |
Nov 07 2016 | CAH | CARDINAL HEALTH IN ... | KING DAVID P | Director | Grant | A | 0.00 | 2,447 | 0 | 18,421 | 16 K to 18.4 K (+15.32 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 70.15 | 72,561 | 5,090,154 | 0 | |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 70.15 | 123,839 | 8,687,306 | 72,561 | |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 127.65 | 72,561 | 9,262,143 | 147,371 | 219.9 K to 147.4 K (-32.99 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 70.15 | 72,561 | 5,090,154 | 219,932 | 147.4 K to 219.9 K (+49.24 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 129.47 | 4,500 | 582,626 | 147,371 | 151.9 K to 147.4 K (-2.96 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 128.79 | 45,884 | 5,909,607 | 151,871 | 197.8 K to 151.9 K (-23.20 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 127.76 | 73,455 | 9,384,772 | 197,755 | 271.2 K to 197.8 K (-27.08 %) |
Jun 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 70.15 | 123,839 | 8,687,306 | 271,210 | 147.4 K to 271.2 K (+84.03 %) |
Apr 01 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 117.85 | 48,425 | 5,706,886 | 147,371 | 195.8 K to 147.4 K (-24.73 %) |
Apr 01 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 101,307 | 0 | 195,796 | 94.5 K to 195.8 K (+107.22 %) |
Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 6,076 | 0 | 43,128 | |
Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 115.49 | 2,905 | 335,498 | 94,489 | 97.4 K to 94.5 K (-2.98 %) |
Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 6,076 | 0 | 97,394 | 91.3 K to 97.4 K (+6.65 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,270 | 0 | 49,204 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,343 | 0 | 57,474 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 103.02 | 3,735 | 384,780 | 91,318 | 95.1 K to 91.3 K (-3.93 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,270 | 0 | 95,053 | 86.8 K to 95.1 K (+9.53 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 101.40 | 2,768 | 280,675 | 86,783 | 89.6 K to 86.8 K (-3.09 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,343 | 0 | 89,551 | 81.2 K to 89.6 K (+10.27 %) |
Feb 11 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 22,630 | 0 | 65,817 | |
Nov 05 2015 | CAH | CARDINAL HEALTH IN ... | KING DAVID P | Director | Grant | A | 0.00 | 1,848 | 0 | 15,974 | 14.1 K to 16 K (+13.08 %) |
Aug 05 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 80.37 | 50,000 | 4,018,500 | 0 | |
Aug 05 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 128.43 | 16,300 | 2,093,473 | 81,153 | 97.5 K to 81.2 K (-16.73 %) |
Aug 05 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 127.68 | 33,700 | 4,302,870 | 97,453 | 131.2 K to 97.5 K (-25.70 %) |
Aug 05 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 80.37 | 50,000 | 4,018,500 | 131,153 | 81.2 K to 131.2 K (+61.61 %) |
Jul 06 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 80.37 | 50,000 | 4,018,500 | 50,000 | |
Jul 06 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 122.04 | 29,490 | 3,598,892 | 66,063 | 95.6 K to 66.1 K (-30.86 %) |
Jul 06 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 121.41 | 20,510 | 2,490,131 | 95,553 | 116.1 K to 95.6 K (-17.67 %) |
Jul 06 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 80.37 | 50,000 | 4,018,500 | 116,063 | 66.1 K to 116.1 K (+75.69 %) |
Jun 03 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 80.37 | 50,000 | 4,018,500 | 100,000 | |
Jun 03 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 118.59 | 49,091 | 5,821,702 | 65,899 | 115 K to 65.9 K (-42.69 %) |
Jun 03 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 117.87 | 909 | 107,144 | 114,990 | 115.9 K to 115 K (-0.78 %) |
Jun 03 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 80.37 | 50,000 | 4,018,500 | 115,899 | 65.9 K to 115.9 K (+75.87 %) |
Apr 01 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 127.28 | 3,974 | 505,811 | 65,899 | 69.9 K to 65.9 K (-5.69 %) |
Apr 01 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 8,330 | 0 | 69,873 | 61.5 K to 69.9 K (+13.54 %) |
Mar 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 18,230 | 0 | 43,187 | |
Mar 04 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 123.36 | 3,515 | 433,610 | 61,543 | 65.1 K to 61.5 K (-5.40 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | KING DAVID P | EVP, Strategic Plan ... | Payment of Exercise | F | 38.05 | 2,276 | 86,602 | 10,582 | 12.9 K to 10.6 K (-17.70 %) |
Feb 19 2004 | LH | LABORATORY CORP OF ... | KING DAVID P | EVP, Strategic Plan ... | Option Exercise | A | 39.00 | 45,000 | 1,755,000 | 45,000 |
Page: 1